Physician profile
Robert K Rockower
NPI 1437139789
$36,441.73
in general payments reported to CMS, 2019-2025
70 companies · $4,011 in 2025
The $4,011 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,953 · 2020: $4,068 · 2021: $5,923 · 2022: $5,885 · 2023: $4,473 · 2024: $5,129 · 2025: $4,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,613.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,237.77 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $3,686.55 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $2,974.31 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $2,554.11 | 2019-2025 | Repatha, Otezla, Evenity |
| Lilly USA, LLC | $1,989.37 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $1,486.60 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,451.54 | 2019-2025 | Jardiance |
| Pfizer INC. | $1,439.44 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,324.97 | 2019-2025 | Zeposia |
| Amarin Pharma, INC. | $1,301.32 | 2019-2022 | |
| Glaxosmithkline, LLC. | $1,089.94 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $907.33 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $779.94 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $705.86 | 2021-2025 | Rexulti, Abilify Maintena |
| Sanofi-Aventis U.S. LLC | $695.18 | 2019-2023 |
Show all 70 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $691.36 | 2021-2025 | Vyepti, Rexulti |
| Novartis Pharmaceuticals Corporation | $554.66 | 2019-2024 | |
| Sunovion Pharmaceuticals INC. | $492.93 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $432.64 | 2024-2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $409.08 | 2022-2023 | |
| Allergan, INC. | $393.85 | 2019-2020 | |
| Esperion Therapeutics, INC. | $373.65 | 2020-2024 | Nexletol |
| Harmony Biosciences LLC | $328.00 | 2020-2022 | |
| Acadia Pharmaceuticals INC | $317.16 | 2024-2025 | Nuplazid |
| Astellas Pharma US INC | $315.81 | 2023-2025 | Veozah, Myrbetriq |
| Sk Life Science, INC. | $310.25 | 2021-2023 | Xcopri |
| Ironwood Pharmaceuticals, INC | $295.85 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $293.84 | 2020-2022 | |
| Eisai INC. | $255.91 | 2020-2022 | |
| Exact Sciences Corporation | $244.45 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Tg Therapeutics, INC. | $232.12 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $229.48 | 2022 | |
| Abbott Laboratories | $218.62 | 2019-2025 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $215.37 | 2022-2023 | Quviviq |
| Merck Sharp & Dohme LLC | $210.29 | 2019-2022 | |
| Axsome Therapeutics, INC. | $192.23 | 2024-2025 | Auvelity |
| Impel Pharmaceuticals INC. | $190.50 | 2022 | |
| Stryker Corporation | $160.14 | 2023 | Mako |
| Boston Scientific Corporation | $156.30 | 2019-2024 | Watchman Flx |
| Vanda Pharmaceuticals INC. | $155.50 | 2024-2025 | Fanapt, Hetlioz |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.60 | 2019-2025 | Xifaxan, Trulance |
| Nevro Corp. | $138.99 | 2022 | |
| Edwards Lifesciences Corporation | $136.96 | 2025 | Sapien 3 Ultra Resilia |
| Avadel Cns Pharmaceuticals, LLC | $125.76 | 2025 | Lumryz |
| Regeneron Healthcare Solutions, INC. | $124.99 | 2019 | |
| United Therapeutics Corporation | $124.99 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.26 | 2019-2025 | Trintellix |
| Medtronic Vascular, INC. | $118.17 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $115.88 | 2019-2020 | |
| Silk Road Medical, INC. | $101.92 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Corium, LLC | $90.92 | 2023 | Adlarity |
| Tesaro, INC. | $87.26 | 2019 | |
| Xeris Pharmaceuticals, INC. | $79.03 | 2024-2025 | Keveyis |
| Avanir Pharmaceuticals, INC. | $73.31 | 2019 | |
| Myriad Women'S Health, INC. | $72.45 | 2023 | Bracanalysis Cdx |
| Dexcom, INC. | $62.73 | 2021-2024 | Dexcom G6 Transmitter |
| Lexicon Pharmaceuticals, INC. | $62.23 | 2024 | Inpefa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.59 | 2024-2025 | Caplyta |
| Sumitomo Pharma America, INC. | $43.93 | 2023 | Gemtesa |
| Jazz Pharmaceuticals INC. | $40.71 | 2020-2021 | |
| Celgene Corporation | $38.47 | 2020 | |
| Medtronic, INC. | $35.38 | 2021-2024 | Intellis Adaptivestim |
| Genzyme Corporation | $34.62 | 2025 | |
| Arbor Pharmaceuticals, INC. | $26.86 | 2019 | |
| Biomarin Pharmaceutical INC. | $22.14 | 2024 | Voxzogo 1.2mg |
| Collegium Pharmaceutical, INC. | $19.11 | 2025 | Jornay Pm |
| Alnylam Pharmaceuticals INC. | $18.02 | 2022 | |
| Biogen, INC. | $15.54 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.37 | 2021 | |
| Shire North American Group INC | $13.32 | 2019 |
Drugs and devices associated with these payments
Breztri $824Airsupra $817Vraylar $742Qulipta $683Zeposia $644Rexulti $571Vyepti $556Ozempic $553Repatha $527Ubrelvy $516Mounjaro $499Otezla $497Eliquis $460Nurtec Odt $440Voquezna $433Jardiance $429Farxiga $342Nuplazid $317Wegovy $302Rybelsus $301Veozah $291Creon $243Briumvi $232Kerendia $229Zepbound $224Enroute Transcarotid Neuroprotection System $204Auvelity $192Quviviq $190Cologuard Collection Kit $182Zavzpret $176Shingrix $162Mako $160Fanapt $156Arexvy $146Paxlovid $138Sapien 3 Ultra Resilia $137Xarelto $132Lumryz $126Xcopri $124Evenity $106Enroute Transcarotid Stent $102Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter $102Linzess $93.24Adlarity $90.92Trelegy Ellipta $90.60Keveyis $79.03Comirnaty $74.10Xifaxan $74.04Bracanalysis Cdx $72.45Freestyle Libre 3 $65.31Soliqua 100/33 $63.33The Cologuard Plus Collection Kit $62.83Inpefa $62.23Prevnar 20 $55.28Abilify Maintena $54.74Trintellix $53.57Hetlioz $51.66Viberzi $50.96Caplyta $47.59Emgality $45.50Gemtesa $43.93Nexletol $43.41Abrysvo $40.32Dexcom G6 Transmitter $38.53Watchman Flx $37.14Aldurazyme $34.62Trulance $33.28Entresto $32.83Leqvio $32.83Myrbetriq $25.22Voxzogo 1.2mg $22.14Jornay Pm $19.11Intellis Adaptivestim $17.48Trumenba $14.96
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rockower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.